AIDS: A Patient Guide
At a Glance
AIDS is an advanced clinical stage of HIV, not an automatic terminal prognosis. Consistent antiretroviral therapy can suppress the virus, support immune recovery, and allow most people with HIV to live long, active lives; sustained undetectable levels prevent sexual transmission.
HIV (Human Immunodeficiency Virus) is a virus that gradually weakens the immune system by targeting the very cells responsible for defending your body against infection. If the virus is left untreated over many years, the immune system can become severely damaged, reaching a stage known as AIDS (Acquired Immunodeficiency Syndrome). While these terms were once associated with a terminal prognosis, the landscape of HIV care has been fundamentally transformed by modern medicine. Today, AIDS is understood as a clinical stage of infection. While an AIDS diagnosis remains part of your medical history, your immune function can recover and your prognosis can greatly improve through consistent treatment [1][2].
The biological mechanism of HIV involves the virus using your body’s immune cells to replicate itself, a process that leads to the depletion of these vital defenses. However, the standard of care, known as Antiretroviral Therapy (ART), effectively interrupts this cycle. By taking a daily regimen of medication, you can lower the amount of virus in your blood to suppressed levels. This durable viral suppression allows your immune system to recover and protects you from the illnesses that characterize advanced HIV [3][4].
Living with HIV today means managing a chronic condition. One of the most significant breakthroughs in this journey is the principle of U=U (Undetectable = Untransmittable). When the virus is suppressed to undetectable levels (generally defined as an HIV RNA viral load below 200 copies/mL) and maintained, it cannot be passed to sexual partners [5][6]. It is important to note that U=U applies specifically to sexual transmission; it does not prevent other sexually transmitted infections (STIs) or pregnancy, and it has not been established as zero-risk protection for sharing injection equipment or breastfeeding. Ongoing monitoring is essential, and you should contact your care team if your viral load rebounds. With early diagnosis and a commitment to treatment, most people living with HIV can expect to lead long, active lives.
In this guide
6 chapters
Understanding Your Diagnosis: HIV and AIDS
Learn what HIV and AIDS stages mean, how CD4 results define stages, how ART supports immune recovery, and when U=U means near-zero sexual transmission risk.
Recognizing Symptoms and Warning Signs
Learn the early and advanced HIV/AIDS symptoms, emergency warning signs, and when to seek urgent care, including fever, breathing trouble, and vision changes.
Navigating Your Lab Results
Learn how to read HIV and AIDS lab results, including CD4 count, viral load, resistance testing, organ function, hepatitis screening, and baseline tests for ART.
Standard of Care: Antiretroviral Therapy (ART)
Learn how antiretroviral therapy treats HIV, including AIDS, and covers INSTIs, adherence, drug interactions, hepatitis B, kidney disease, and injectable ART.
Preventing Opportunistic Infections (Prophylaxis)
Learn when HIV/AIDS prophylaxis is needed to prevent PCP, toxoplasmosis, and MAC, which medicines are used, and when prophylaxis may safely stop after ART.
Long-Term Monitoring and Living Well with HIV
Learn how long-term HIV care tracks viral load, CD4 count, heart, bone, kidney, cancer, and mental health, plus U=U while taking ART for lifelong health.
Common questions in this guide
How are HIV and AIDS different?
Can treatment help my immune system recover after an AIDS diagnosis?
What does U=U mean if I have HIV?
How does antiretroviral therapy work?
What is the outlook after an AIDS diagnosis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my current results, what is the immediate goal for my immune system recovery?
- 2.What is the best way for us to communicate between appointments if I have concerns about symptoms or side effects?
- 3.How will we coordinate my HIV care with other health screenings or conditions I may have?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (6)
- 1
AIDS-related opportunistic illnesses and early initiation of HIV care remain critical in the contemporary HAART era: a retrospective cohort study in Taiwan.
Lee CY, Tseng YT, Lin WR, et al.
BMC infectious diseases 2018; (18(1)):352 doi:10.1186/s12879-018-3251-1.
PMID: 30055564 - 2
Effects of Antiretroviral Therapy on CD4+ Cell Count, HIV Viral Load and Death in a South African Cohort: A Modelling Study.
Shoko C, Chikobvu D, Bessong PO
Pakistan journal of biological sciences : PJBS 2020; (23(4)):542-551 doi:10.3923/pjbs.2020.542.551.
PMID: 32363840 - 3
Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016.
Lecher S, Williams J, Fonjungo PN, et al.
MMWR. Morbidity and mortality weekly report 2016; (65(47)):1332-1335 doi:10.15585/mmwr.mm6547a2.
PMID: 27906910 - 4
Five-Year Immune Recovery After ART Initiation Among PLWH Aged ≥15 Years with Baseline Immunosuppression - China, 2013-2024.
Geng Y, Jia H, Guan Y, et al.
China CDC weekly 2026; (8(25)):772-779 doi:10.46234/ccdcw2026.125.
PMID: 42433220 - 5
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
Rodger AJ, Cambiano V, Bruun T, et al.
Lancet (London, England) 2019; (393(10189)):2428-2438 doi:10.1016/S0140-6736(19)30418-0.
PMID: 31056293 - 6
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.
, Lundgren JD, Babiker AG, et al.
The New England journal of medicine 2015; (373(9)):795-807 doi:10.1056/NEJMoa1506816.
PMID: 26192873
This page is for informational purposes only and does not constitute medical advice about HIV or AIDS. Discuss your test results, treatment, and viral-load monitoring with your HIV care team.
Get notified when new evidence is published on AIDS.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.